(Q33990027)
Statements
1 reference
Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge (English)
1 reference
Yee Ean Ong
1 reference
Andrew Menzies-Gow
1 reference
Julia Barkans
1 reference
Farid Benyahia
1 reference
Tsen-Teng Ou
1 reference
Sun Ying
1 reference
A Barry Kay
1 reference
1 September 2005
1 reference
1 reference
116
1 reference
558-564
1 reference
Identifiers
1 reference
1 reference